As many as 450 people, including six who have died, have been affected by a vaping-related respiratory illness in recent weeks
Inc () (OTCMKST:TGIFF) on Tuesday assured its stakeholders that the cannabis company is deeply committed to the safety and quality of its vape products.
The company issued the statement following a recent CDC a warning about e-cigarettes and vaping products. As many as 450 people, including six who have died, have been affected by a vaping-related respiratory illness.
“Many of our close business partners, loyal customers and shareholders have made inquiries regarding our proprietary branded vape products in light of the possible cases of lung illness associated with using e-cigarettes,” 1933 Industries said.
“Although little is known about each individual case, we feel that it is our duty and obligation to assure our stakeholders of our deep commitment to safety and quality.”
READ: 1933 Industries bolsters its portfolio in Nevada with the launch of blonde cannabis
The company noted that all of its branded THC and CBD vape products do not contain vitamin E acetate, vegetable glycerin, or propylene glycol.
“All our products are made with ingredients that are known to be safe for consumers. All packaging contains our product ingredients, which are also listed on our website. Each and every product is third-party lab tested, and the results can be tracked via a QR code,” 1993 Industries said, adding that it “offers a unique approach to compliance and transparency.”
For example, the company said that all of its Canna Hemp products undergo rigorous testing to ensure the purity and safety of its CBD -- which is tested by independent certified labs to ensure it is THC-free and contains no harmful chemicals or pesticides. The finished product also is lab tested and labeled with a QR code linking to the lab results.
“We value your continued support and loyalty to our products,” the company concluded in its statement.
1993 Industries, based in Vancouver, owns licensed medical and adult-use cannabis cultivation and production assets, proprietary hemp-based, CBD infused branded products, CBD extraction services and a specialized cannabis advisory firm.
Contact the author: [email protected]
Follow him on Twitter @PatrickMGraham